Evolus, Inc. Common Stock(EOLS)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

EOLS $7.84
Snapshot
$7.84
52-Week Range
$3.86 – $9.31
YTD
+16.67%
IV Rank (30D)
30.75
Straddle Price
$1.27
P/C Vol Ratio
2.85
Market Cap
$0.5B
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.80%
Beta vs SPY1.07
Cost of Equity (CAPM)10.71% (VRP-adj)
WACC9.17%
Volatility Risk Premium+76.9pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+21.9%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)111.1%
Book / Price-6.0%
Gross Margin (TTM)66.7%
FCF Margin (TTM)-6.4%
Quality Score3/6 — normal (10y DCF)
SMA 50$7.35 (Market Anchor value)
SMA 20 / Bollinger Mid$8.64
Bollinger Width / SMA20233.0% (drives anchor stability)
Net Debt$0.1B
Market Cap$1B
Peers used for multiples: AMLX, ATAI, DFTX, JNJ, LLY, MBX, MRK, OMER
Model Conviction
95%
20-Day Fair Value
≈ by Oct 12, 2026
ACTIVE
$8.94
α +14.0% rank 98%
40-Day Fair Value
≈ by Nov 10, 2026
ACTIVE
$9.62
α +22.7% rank 98%
60-Day Fair Value
≈ by Dec 9, 2026
ACTIVE
$9.33
α +19.0% rank 96%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 34.1× · 4 peers
Peer EV/EBITDA n/a 0% median 25.1× · 3 peers
Peer P/B n/a 0% median 8.7× · 5 peers
Peer P/S $51.22 15% median 9.6× · 4 peers
Market Anchor (SMA50) $7.35 85% stability 85% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-09-11 · updated
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.5B

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The…

Summary
composite
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +13.46% 6
Feb +13.40% 6
Mar -3.62% 6
Apr -0.11% 6
May +2.39% 6
Jun -4.82% 6
Jul +4.54% 6
Aug +9.45% 6
Sep -13.61% 6
Oct +0.72% 5
Nov -5.00% 5
Dec +2.70% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $8.63
SMA 50: $7.37
SMA 200: $6.09
Current: $7.84
EMA 12: $8.54
EMA 26: $8.25
MACD: 0.2861 | Signal: -0.1896
BULLISH
ADX (14): 38.66
TREND
+DI: 20.86
−DI: 24.85

Momentum Oscillators

RSI (14): 43.48
NEUTRAL
Stoch %K: 15.73
Stoch %D: 37.80
Williams %R: -94.23

Volume & Volatility

BB Upper: $9.52
BB Lower: $7.73
NEUTRAL
OBV: -26,149,997
Vol SMA 20: 970,727
Vol ROC: -50.92%
ATR: $0.41
True Range: $0.34
HV 20: 55.2%
HV 30: 76.2%
HV 60: 61.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-13T00:00:00 – 2026-09-11T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
9 of 9 under expected move
Avg Expected Move
26.16%
Avg Actual Move
4.07%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-11-06 After-Close 15.76% 14.99% 0.95x Within
2025-01-21 After-Close 18.70% 2.81% 0.15x Within
2025-05-07 Pre-Market 14.33% 1.58% 0.11x Within
2025-08-05 Pre-Market 18.66% 3.95% 0.21x Within
2025-11-05 After-Close 36.59% 3.01% 0.08x Within
2026-01-09 Pre-Market 12.64% 2.09% 0.17x Within
2026-03-03 Pre-Market 72.67% 1.97% 0.03x Within
2026-05-04 Pre-Market 18.76% 5.25% 0.28x Within
2026-08-05 Pre-Market 27.37% 0.98% 0.04x Within
Options Activity
IV Rank (30D)
30.75
IV Rank (7D)
100
Avg IV
134.9%
Straddle (30D)
$1.27
Straddle (7D)
$0.75
P/C Volume
2.85
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.09
Correlation (SPY)
20.8%
0.04
Ann. Volatility
67.3%
SPY Volatility
12.8%

Above average volatility - stock moves with market amplification

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 65,077,726 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

161 filers51,585,894 shares$354.45M value79.27% of float
# Filer Shares Value % of Total % of Float Period
1 Nantahala Capital Management, LLC 5,602,021 $38.88M 10.97% 8.61% 2026-06-30
2 BlackRock, Inc. Custodian 4,840,828 $33.60M 9.48% 7.44% 2026-06-30
3 VANGUARD GROUP INC Custodian 3,341,804 $22.22M 6.27% 5.14% 2025-12-31
4 BRAIDWELL LP 3,155,209 $21.90M 6.18% 4.85% 2026-06-30
5 Frazier Life Sciences Management, L.P. 2,630,665 $18.26M 5.15% 4.04% 2026-06-30
6 PERCEPTIVE ADVISORS LLC 2,459,285 $17.07M 4.82% 3.78% 2026-06-30
7 VANGUARD CAPITAL MANAGEMENT LLC 2,362,893 $16.40M 4.63% 3.63% 2026-06-30
8 MILLENNIUM MANAGEMENT LLC Custodian 1,787,929 $12.41M 3.50% 2.75% 2026-06-30
9 STATE STREET CORP 1,697,294 $11.78M 3.32% 2.61% 2026-06-30
10 GEODE CAPITAL MANAGEMENT, LLC Custodian 1,608,394 $11.17M 3.15% 2.47% 2026-06-30
11 Stonepine Capital Management, LLC 1,590,162 $11.04M 3.11% 2.44% 2026-06-30
12 Point72 Asset Management, L.P. 1,508,518 $10.47M 2.95% 2.32% 2026-06-30
13 PINNACLE ASSOCIATES LTD 1,487,264 $10.32M 2.91% 2.29% 2026-06-30
14 ARMISTICE CAPITAL, LLC 1,436,000 $9.97M 2.81% 2.21% 2026-06-30
15 RICE HALL JAMES & ASSOCIATES, LLC 1,289,888 $8.95M 2.53% 1.98% 2026-06-30
16 GOLDMAN SACHS GROUP INC Custodian 1,219,419 $8.46M 2.39% 1.87% 2026-06-30
17 Assenagon Asset Management S.A. 908,180 $6.30M 1.78% 1.40% 2026-06-30
18 Soleus Capital Management, L.P. 822,428 $5.71M 1.61% 1.26% 2026-06-30
19 Soviero Asset Management, LP 770,000 $5.34M 1.51% 1.18% 2026-06-30
20 UBS Group AG Custodian 752,679 $5.22M 1.47% 1.16% 2026-06-30
21 AWH Capital, L.P. 625,000 $4.34M 1.22% 0.96% 2026-06-30
22 VANGUARD PORTFOLIO MANAGEMENT LLC 545,702 $3.79M 1.07% 0.84% 2026-06-30
23 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 530,843 $3.68M 1.04% 0.82% 2026-06-30
24 CITADEL ADVISORS LLC Custodian 506,354 $3.51M 0.99% 0.78% 2026-06-30
25 NORTHERN TRUST CORP Custodian 497,018 $3.45M 0.97% 0.76% 2026-06-30
7 filers$5.19M notional
# Filer Notional Value % of Total Period
1 Stonepine Capital Management, LLC $3.15M 60.73% 2026-06-30
2 DIADEMA PARTNERS LP $1.39M 26.76% 2026-06-30
3 Caption Management, LLC $402.52K 7.76% 2026-06-30
4 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $204.04K 3.93% 2026-06-30
5 SIMPLEX TRADING, LLC Custodian $28.45K 0.55% 2026-06-30
6 Persistent Asset Partners Ltd $10.24K 0.20% 2026-06-30
7 GROUP ONE TRADING LLC Custodian $3.47K 0.07% 2026-06-30
6 filers$2.01M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $1.39M 68.94% 2026-06-30
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $406.68K 20.20% 2026-06-30
3 SIMPLEX TRADING, LLC Custodian $115.20K 5.72% 2026-06-30
4 CITADEL ADVISORS LLC Custodian $88.83K 4.41% 2026-06-30
5 GROUP ONE TRADING LLC Custodian $13.88K 0.69% 2026-06-30
6 Walleye Capital LLC $694 0.03% 2026-06-30
Insider Activity
Latest: 2026-09-04
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-04 DAVID MOATAZEDI See Remarks Sell (S) −105,108 $9.04 -$950.0K EDGAR
2026-03-20 DAVID MOATAZEDI See Remarks Sell (S) −13,669 $4.75 -$64.9K EDGAR
2026-03-20 Rui Avelar See Remarks Sell (S) −3,119 $4.75 -$14.8K EDGAR
2026-03-18 DAVID MOATAZEDI See Remarks Mixed −49,231 $4.89 -$570.6K EDGAR
2026-03-18 Rui Avelar See Remarks Mixed −21,192 $4.89 -$146.6K EDGAR
2026-02-19 Rui Avelar See Remarks Award (A) +94,913 EDGAR
2026-02-19 DAVID N GILL Director Award (A) +45,559 EDGAR
2026-02-19 Albert G White III Director Award (A) +45,559 EDGAR
2026-02-19 Vikram Malik Director Award (A) +45,559 EDGAR
2026-02-19 DAVID MOATAZEDI See Remarks Award (A) +313,212 EDGAR
2026-02-19 Karah Herdman Parschauer Director Award (A) +45,559 EDGAR
2026-02-19 Tatjana Mitchell Chief Financial Officer Award (A) +121,489 EDGAR
2026-02-19 Brady Stewart Director Award (A) +45,559 EDGAR
2025-12-29 Rui Avelar See Remarks Sell (S) −2,261 $7.15 -$16.2K EDGAR
2025-12-29 DAVID MOATAZEDI See Remarks Sell (S) −10,539 $7.15 -$75.4K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
20 insiders · @ $7.84
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Medytox Inc. 10%+ Owner 10,640,826 $83.42M -$25.75M 15 2023-10-18
2 Alphaeon 1 LLC 10%+ Owner 4,214,871 $33.04M -$40.22M 2 2023-02-22
3 SIMONE BLANK Director 559,894 $4.39M $16.41M 12 2025-03-11
4 DAVID MOATAZEDI See Remarks 499,592 $3.92M -$16.01M 37 2026-09-04
5 Rui Avelar See Remarks 427,423 $3.35M -$1.91M 25 2026-03-20
6 Vikram Malik Director 321,109 $2.52M $24.56M 19 2026-02-19
7 Tatjana Mitchell Chief Financial Officer 226,092 $1.77M $0 2 2026-02-19
8 Michael M. Jafar See Remarks 219,851 $1.72M $246.5K 8 2021-02-01
9 Sandra Beaver Chief Financial Officer 167,089 $1.31M -$437.7K 13 2025-05-14
10 LAUREN P SILVERNAIL See Remarks 141,571 $1.11M -$1.03M 12 2022-05-18
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2025-06-16
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-06-16 DAVID MOATAZEDI Officer, Director 16,582 $164.1K 2025-06-16 Morgan Stanley Smith Barney LLC … EDGAR
2025-06-13 DAVID MOATAZEDI Officer, Director 111,323 $1.12M 2025-06-13 Morgan Stanley Smith Barney LLC … EDGAR
2025-03-12 Parschauer Karah Herdman Director 12,888 $167.5K 2025-03-12 Morgan Stanley Smith Barney LLC … EDGAR
2024-06-06 MOATAZEDI DAVID Officer 200,000 $2.54M 2024-06-06 MORGAN STANLEY SMITH BARNEY LLC … EDGAR
2024-06-05 MOATAZEDI DAVID Officer 155,278 $1.97M 2024-06-05 Morgan Stanley Smith Barney LLC … EDGAR
2024-06-04 MOATAZEDI DAVID Officer 140,214 $1.78M 2024-06-04 Morgan Stanley Smith Barney LLC … EDGAR
2024-06-03 Malik Vikram Officer 7,500 $97.2K 2024-06-03 Morgan Stanley Smith Barney LLC … EDGAR
2024-05-14 Malik Vikram Director 28,000 $362.0K 2024-05-13 Morgan Stanley Smith Barney LLC … EDGAR
2024-05-13 GILL DAVID N Director 10,361 $131.6K 2024-05-13 Morgan Stanley Smith Barney LLC … EDGAR
2024-01-30 KARAH PARSCHAUER Director 11,931 $156.7K 2024-01-30 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-16.9
P/S Ratio1.6
EV/EBITDA-93.7
TTM Revenue$0.3B
TTM Net Income$-0.0B
TTM EPS$-0.52
ROE111.1%
Debt/Equity-6.05